Ocular Therapeut
(OCUL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 80,892 | 19,944 | 0 | N/A | 0 |
| Receivables | 54 | 61 | 0 | N/A | 0 |
| Inventories | 117 | 109 | 0 | N/A | 0 |
| Other current assets | 0 | 2,197 | 0 | 0 | 0 |
| TOTAL | $82,274 | $22,594 | $0 | $N/A | $0 |
| Non-Current Assets | |||||
| PPE Net | 1,376 | 1,152 | N/A | N/A | N/A |
| Other Non-Current Assets | 228 | 228 | 0 | 0 | 0 |
| TOTAL | $1,604 | $1,380 | $N/A | $N/A | $N/A |
| Total Assets | $83,878 | $23,974 | $0 | $N/A | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 649 | 1,525 | 0 | 0 | 0 |
| Accrued Expenses | 2,480 | 1,629 | 0 | N/A | 0 |
| TOTAL | $3,379 | $4,489 | $0 | $N/A | $0 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,776 | 13,594 | 0 | N/A | 0 |
| Deferred Revenues | 250 | 250 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 0 | 75,207 | 0 | 0 | 0 |
| TOTAL | $14,897 | $88,920 | $N/A | $N/A | $N/A |
| Total Liabilities | $18,276 | $93,409 | $0 | $N/A | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,322 | 21,319 | N/A | N/A | N/A |
| Common Shares | 2 | N/A | 0 | N/A | 0 |
| Retained earnings | -81,474 | -74,180 | 0 | N/A | 0 |
| TOTAL | $65,602 | $-69,435 | $0 | $N/A | $0 |
| Total Liabilities And Equity | $83,878 | $23,974 | $0 | $0 | $0 |